Multi-Cancer Early Detection

What's included in every program

Screen for up to 50 Cancers in a Single Blood Test

Traditional screening methods often focus on one or a few cancers at a time. LucenceINSIGHT™ offers a more comprehensive and convenient solution.

01
Broad Multi-Cancer Screening in a Single Blood Test
Instead of multiple screening procedures, LucenceINSIGHT™ uses a single blood draw to screen for signals associated with up to 50 types of cancer. This broad screening approach is particularly relevant because many cancer-related deaths occur in cancers for which routine screening is not currently available.
02
Powered by Circulating Tumour DNA (ctDNA) Technology
LucenceINSIGHT™ analyses circulating tumour DNA (ctDNA) — small fragments of DNA that may be released into the bloodstream by tumour cells. By identifying these molecular signals, the test may help detect cancer-associated signals before clinical symptoms develop in some individuals.
03
Supporting Earlier Conversations About Your Health
When cancer-associated signals are detected, LucenceINSIGHT™ may help support earlier clinical evaluation and appropriate follow-up investigations. Earlier identification of potential cancer signals may provide patients and their healthcare professionals with more time to determine the next appropriate steps.
04
Simple, Convenient, and Non-Invasive
LucenceINSIGHT™ is a multi-cancer early detection (MCED) blood test that screens for circulating tumour DNA (ctDNA) signals associated with up to 50 types of cancer using a single blood draw.
05
High Accuracy
In a clinical validation study, LucenceINSIGHT™ demonstrated an overall sensitivity of 80.9% and specificity of 99.2%. Sensitivity refers to the ability to correctly identify cancers when present, while specificity refers to correctly identifying individuals without cancer.

Speak with our team

Screening Types

Which Multi-Cancer Early Detection test (MCED) is right for you?

LucenceINSIGHT™ screens for the risk of cancer with a sensitivity of 80.9%, which means that it has an 80.9% chance to correctly detect cases of the particular disease in question. It also has a specificity of 99.2%, which means that it can correctly identify when a person being tested does not have the disease 99.2% of the time.

NOVI

LucenceINSIGHT™ Core

Screens for the risk of 6 types of cancer

$600(incl. GST)

Lung
Thyroid
Liver
Pancreatic
Colorectal cancer
Breast

Get Started

NOVI

LucenceINSIGHT™ 12

Screens for the risk of 12 types of cancer in men and women

$1,939(incl. GST)

Programme details coming soon.

Get Started

NOVI

LucenceINSIGHT™ 50

Screens for the risk of 50 types of cancer — for those 40+ or at higher cancer risk

$3,800(incl. GST)

Programme details coming soon.

Get Started

Price

Test	Price (inclusive of GST)
Doctor consultation (for pre and post review)	$54.50
LucenceINSIGHT™ Core	$600
LucenceINSIGHT™ 12	$1,939
LucenceINSIGHT™ 50	$3,800

Prices are inclusive of GST. Prices above apply if the LucenceINSIGHT™ test is done as part of health screening or as an addition to other NOVI services. If you choose a standalone Multi-Cancer Early Detection (MCED) test, a doctor consultation fee of $54.50 is applicable.

Speak with our team

Start with an assessment.
Move forward with clarity.

Get a clear picture of where you stand, and a plan designed around your real life.

Take an assessment Speak with our team

How It Works

A Simple Path to Powerful Insights

We've streamlined the process to make cancer screening accessible.

01
Consult Your Doctor
Begin with a consultation where our doctor will assess your individual health profile, discuss any risk factors, and determine if LucenceINSIGHT™ is right for you. Consultation can be done in the clinic or online.
02
Simple Blood Draw
A quick and easy blood sample is collected at our clinic.
03
Advanced Laboratory Analysis
Your sample is sent to the laboratory, where the blood sample is analyzed for ctDNA signals associated with up to 50 different cancers.
04
Clear Results & Expert Review
Once your results are ready (indicating whether cancer signals were "Detected" or "Not Detected"), you'll have a follow-up consultation with your doctor. They will explain your results thoroughly and discuss any recommended next steps.